Literature DB >> 4026963

Analysis and subcellular localization of lipid in alcoholic liver disease.

T J Peters, S R Cairns.   

Abstract

The nature and subcellular distribution of lipids in alcoholic liver disease have been little studied. Micro-methods for lipid analysis were applied to needle biopsy homogenates and their subcellular fractions. Alcoholic fatty liver was accompanied by a major increase (up to 50 fold) in triglyceride and a smaller (2-3 fold) increase in cholesteryl ester: there was no significant change in the free cholesterol, free fatty acid or phospholipid content. Homogenates were fractionated into macro- and micro-droplets and membrane fractions by differential centrifugation. The subcellular location of the membrane lipids were determined by sucrose density gradient centrifugation in a vertical pocket reorientating rotor. In fatty liver, although there was a 2-3 fold increase in macro-droplet and micro-droplet (tentatively identified as VLDL) lipid, the major increase was in the membrane-bound triglyceride (8-10 fold). Sucrose density gradient centrifugation demonstrated that these membranes had an equilibrium density of 1.12 g/ml, clearly separated from droplet lipid, density less than 1.04 g/ml. The membrane fraction was tentatively identified as Golgi in origin and it is suggested that alcoholic fatty liver in man is due to impaired Golgi secretion of triglyceride-rich lipid complexes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4026963     DOI: 10.1016/0741-8329(85)90113-2

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  2 in total

1.  Lipid aldehyde-mediated cross-linking of apolipoprotein B-100 inhibits secretion from HepG2 cells.

Authors:  Benjamin J Stewart; James R Roede; Jonathan A Doorn; Dennis R Petersen
Journal:  Biochim Biophys Acta       Date:  2009-04-21

2.  Lipid droplet accumulation and impaired fat efflux in polarized hepatic cells: consequences of ethanol metabolism.

Authors:  Benita L McVicker; Karuna Rasineni; Dean J Tuma; Mark A McNiven; Carol A Casey
Journal:  Int J Hepatol       Date:  2012-03-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.